A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- Oral cancer: Do you have symptoms? New technology could detect disease at an early stageon June 25, 2020 at 5:16 am
ORAL cancer is a tumour that can develop on the tongue, the insides of the cheeks, the roof of the mouth, the lips or gums. Scientists are now working on a pain-free device that'll detect the disease ...
- Whole genome sequencing can improve diagnosis and treatment of patients with rare diseaseson June 24, 2020 at 8:07 pm
A research programme pioneering the use of whole genome sequencing in the NHS has diagnosed hundreds of patients and discovered new genetic causes of disease.
- Genomes front and center of rare disease diagnosison June 24, 2020 at 8:55 am
A research program pioneering the use of whole genome sequencing in the NHS has diagnosed hundreds of patients and discovered new genetic causes of disease. Whole genome sequencing is the technology ...
- Researchers design COVID-19 knowledge base and risk assessment tool powered by AIon June 24, 2020 at 8:01 am
Researchers from Florida Atlantic University's College of Engineering and Computer Science, in collaboration with FAU's Schmidt College of Medicine, have received a one-year, $90,000 National Science ...
- Dominion Diagnostics Offering COVID-19 Serology Antibody Testingon June 24, 2020 at 7:10 am
Dominion Diagnostics is pleased to now offer COVID-19 serology antibody testing. Serological tests for SARS-CoV-2, while not intended as a primary diagnostic tool for COVID-19, are used to detect ...
- Lack of rapid diagnostic tools contributes to Covid-19 deathson June 22, 2020 at 2:03 am
Sepsis is the underlying cause of death in a significant percentage of people with Covid-19. We need better diagnostic tools for both of these diseases.
- Simple blood test could one day diagnose motor neuron diseaseon June 20, 2020 at 11:58 am
Scientists have identified a potential pattern within blood which signals the presence of motor neuron disease; a discovery which could significantly improve diagnosis.
- FDA joins partnership on COVID-19 analytics toolon June 19, 2020 at 12:39 pm
The FDA has joined a multi-institution, public-private research effort to improve the quality and speed of COVID-19 diagnostics. The project, called the COVID-19 Diagnostics Evidence Accelerator, aims ...
- FDA joins new, public-private COVID-19 diagnostic research accelerator efforton June 18, 2020 at 9:51 am
The FDA has joined a public-private diagnostic research project with the goal of bringing more real-world data to bear against the novel coronavirus, and gauging the accuracy of different kinds of ...
- Discovery could significantly improve diagnosis of motor neuron diseaseon June 17, 2020 at 9:46 am
Scientists at the University of Sussex have identified a potential pattern within blood which signals the presence of motor neuron disease; a discovery which could significantly improve diagnosis.
via Bing News